ΚΑΡΚΙΝΟΣ ΠΡΟΣΤΑΤΗ ΤΡΟΦΕΣ
Παραπομπές
1. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a030361. doi: 10.1101/cshperspect.a030361. PMID: 29311132; PMCID: PMC6280714.
https://pubmed.ncbi.nlm.nih.gov/29311132/
2. Chang AJ, Autio KA, Roach M 3rd, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. PMID: 24840073; PMCID: PMC4508854.
https://pubmed.ncbi.nlm.nih.gov/24840073/
3. - - -
1. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a030361. doi: 10.1101/cshperspect.a030361. PMID: 29311132; PMCID: PMC6280714.
https://pubmed.ncbi.nlm.nih.gov/29311132/
2. Chang AJ, Autio KA, Roach M 3rd, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. PMID: 24840073; PMCID: PMC4508854.
https://pubmed.ncbi.nlm.nih.gov/24840073/
3. - - -
